Kodiak Sciences Inc
KOD
NASDAQ
Biotechnology
$41.35
USD
+1.37 (+3.43%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $2.53B
Volume 746.9K
Peer Comparison Table
(1/4) | ||||||
|---|---|---|---|---|---|---|
CLDX | Celldex Therapeutics Inc | $3.36B | - | -97.3% | - | |
GRAL | Grail Inc | $3.34B | - | +19.4% | - | |
ARQT | Arcutis Biotherapeutics Inc | $3.25B | 114.06 | +76.1% | - | |
IRON | Disc Medicine Inc | $3.01B | - | - | - | |
IOVA | Iovance Biotherapeutics Inc | $2.91B | - | +34.5% | - | |
IMNM | Immunome Inc | $2.91B | - | -63.3% | - | |
BEAM | Beam Therapeutics Inc | $2.83B | - | +158.9% | - | |
KOD | Kodiak Sciences Inc | $2.72B | - | - | - | |
NRIX | Nurix Therapeutics Inc | $2.69B | - | -58.4% | - | |
PGEN | Precigen Inc | $2.52B | - | +1875.0% | - |
Top Peer by Growth
Beam Therapeutics Inc
+158.9% YoY Revenue
Lowest P/E Ratio
CareDx Inc
22.08x P/E
Best 1-Year Return
Sellas Life Sciences Group Inc
+697.4% Return